Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells
Gover-Proaktor, Ayala, Granot, Galit, Pasmanik-Chor, Metsada, Pasvolsky, Oren, Shapira, Saar, Raz, Oshrat, Raanani, Pia, Leader, Avi
Published in Leukemia & lymphoma (02.01.2019)
Published in Leukemia & lymphoma (02.01.2019)
Get full text
Journal Article
Using the Iron Chelator Deferasirox to Overcome Drug Resistance in Mantle Cell Lymphoma
Samara, Aladin, Shapira, Saar, Lubin, Ido, Raanani, Pia, Granot, Galit
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species‐ and GSK3β‐dependent mechanism
Samara, Aladin, Shapira, Saar, Lubin, Ido, Shpilberg, Ofer, Avigad, Smadar, Granot, Galit, Raanani, Pia
Published in British journal of haematology (01.02.2021)
Published in British journal of haematology (01.02.2021)
Get full text
Journal Article
Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemia
Samara, Aladin, Anbar, Michael, Shapira, Saar, Zemlyansky, Anna, Zozovsky, Alla, Raanani, Pia, Granot, Galit, Rozovski, Uri
Published in Hematological oncology (01.08.2023)
Published in Hematological oncology (01.08.2023)
Get full text
Journal Article
Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38– cells through iron chelation, induction of ROS, and inhibition of HIF1α expression
Shapira, Saar, Raanani, Pia, Samara, Aladin, Nagler, Arnon, Lubin, Ido, Arber, Nadir, Granot, Galit
Published in Experimental hematology (01.02.2019)
Published in Experimental hematology (01.02.2019)
Get full text
Journal Article
Ponatinib reduces viability, migration, and functionality of human endothelial cells
Gover-Proaktor, Ayala, Granot, Galit, Shapira, Saar, Raz, Oshrat, Pasvolsky, Oren, Nagler, Arnon, Lev, Dorit L., Inbal, Aida, Lubin, Ido, Raanani, Pia, Leader, Avi
Published in Leukemia & lymphoma (03.06.2017)
Published in Leukemia & lymphoma (03.06.2017)
Get full text
Journal Article
Dasatinib induces endothelial dysfunction leading to impaired recovery from ischaemia
Gover‐Proaktor, Ayala, Leshem‐Lev, Dorit, Winograd‐Katz, Sabina, Partouche, Shirly, Samara, Aladin, Shapira, Saar, Nardi‐Agmon, Inbar, Harari, Emanuel, Younis, Aseel, Najjar, Abderrahman, Kornowski, Ran, Geiger, Benjamin, Raanani, Pia, Leader, Avi, Granot, Galit
Published in British journal of haematology (01.09.2024)
Published in British journal of haematology (01.09.2024)
Get full text
Journal Article
Selective Death of Leukemia Initiating Cells Induced By Deferasirox
Shapira, Saar, Raanani, Pia, Nagler, Arnon, Lubin, Ido, Arber, Nadir, Granot, Galit
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Pathogenesis of Ponatinib Associated Vascular Disease in Chronic Myeloid Leukemia: An in Vitro Study
Gover-Proaktor, Ayala, Pasvolsky, Oren, Raanani, Pia, Nagler, Arnon, Shapira, Saar, Lubin, Ido, Granot, Galit, Leader, Avi
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Second-generation tyrosine kinase inhibitors reduce telomerase activity in K562 cells
Shapira, Saar, Granot, Galit, Mor-Tzuntz, Rahav, Raanani, Pia, Uziel, Orit, Lahav, Meir, Shpilberg, Ofer
Published in Cancer letters (28.10.2012)
Published in Cancer letters (28.10.2012)
Get full text
Journal Article